P2.04-60 Pembrolizumab-Based Regimens Administered at Non-Standard Frequency in Non-Small Cell Lung Cancer (NSCLC)
Autor: | Sehgal, K., Shea, M., Mcdonald, D., Huberman, M., Weiss, G., Vanderlaan, P., Costa, D., Rangachari, D. |
---|---|
Zdroj: | In Journal of Thoracic Oncology October 2019 14(10) Supplement:S731-S731 |
Databáze: | ScienceDirect |
Externí odkaz: |